Ultraviolet Blood Irradiation Clinical Trial
We are now offering UVLRx as part of an FDA investigational trial studying the effectiveness on patients with chronic pain. Please call us at 303.884.7557 to see if there are new openings. Read about current clinical trials HERE. Read about the research HERE.
The UVLrx Treatment System administers defined wavelengths to the patient, to address the particular condition(s) being treated. Each wavelength delivered by the UVLrx Treatment System targets specific cells to drive very specific biological pathways:
Red (630 nm) – Upregulates cell bioenergetics helping to bolster immune response and cell repair
UVA (365 nm) – Eradicates foreign pathogens (i.e. bacteria, virus, fungi)
Green (535 nm) – Improves hemodynamics
The UVLrx Treatment System accomplishes all this by bringing light to the patient’s body in a totally new and innovative manner. Housed within our UVLrx Station is an optic engine which is delivered through the Patient Cable and which integrates with the distal end of our patent-pending Dry Light Adapter (DLA) . The DLA feeds an optical filament into a 20-gauge intravascular catheter to provide direct treatment of the blood. During the treatment, normal saline solution flows through the DLA via the saline entry connector preventing light attenuation within the catheter.
In a typical UVLRx treatment three separate wavelengths are delivered to the patient. Each wavelength activates a specific biochemical pathway, with their concurrent powerful and therapeutic effect being the benefit of the UVLrx.
Quality of Life
Auto Immune Disorders
Chronic and Acute Inflammation